<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03202264</url>
  </required_header>
  <id_info>
    <org_study_id>TAPER-Mobility</org_study_id>
    <nct_id>NCT03202264</nct_id>
  </id_info>
  <brief_title>Team Approach to Polypharmacy Reduction to Improve Mobility Long-Term Care</brief_title>
  <official_title>Team Approach to Polypharmacy Reduction to Improve Mobility (TAPER-Mobility): A Pilot Feasibility Study in a Long-Term Care Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Labarge Optimal Aging Initiative</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medication side effects and interactions between medications are very common in older adults&#xD;
      and are related to negative health outcomes, including mobility. In this study, the&#xD;
      investigators will test a new process aimed at reducing unnecessary medication use and drug&#xD;
      side effects in seniors using the best medical evidence and patient preferences for&#xD;
      treatment. This study will assess how feasible the implementation of this intervention is&#xD;
      within a long-term care facility as well as if it is possible. The study will also assess for&#xD;
      any signals of reversal of medications related mobility impairments to reduce&#xD;
      medications-related mobility impairment (fatigue, pain, falls) using the intervention.&#xD;
      Participants in two long-term care facilities will participate in this study. Measures will&#xD;
      include feasibility outcomes regarding the logistics of the intervention as well as patients&#xD;
      outcomes (falls, hospitalizations, and medications) collected before and after&#xD;
      implementation. Findings will inform the design of a randomized controlled trial to test the&#xD;
      effect of this intervention on health outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are substantial associations between polypharmacy and reduced function from older&#xD;
      adults and this is likely to be important in frail older adults both in long term care and in&#xD;
      the community. The reversibility of drug-induced mobility impairment is unclear therefore the&#xD;
      investigators plan to investigate signals of any impact of reducing polypharmacy on mobility.&#xD;
      The investigators chose the long-term care setting given the presence of complete medication&#xD;
      administration records and this patient population's high prevalence of polypharmacy and risk&#xD;
      of adverse drug events. TAPERMD is an electronic tool for systematic medication reduction&#xD;
      that incorporates patient priorities, electronic screening for potentially harmful medicines,&#xD;
      supporting evidence tools and a monitoring pathway to support medication reduction. This&#xD;
      study will examine the feasibility of this tool in a long-term care setting as well as&#xD;
      examine. Participants in two long-term care facilities will participate in this study.&#xD;
      Measures will include feasibility outcomes regarding the logistics of the intervention as&#xD;
      well as patients outcomes (falls, hospitalizations, and medications) collected before and&#xD;
      after implementation. Findings will inform a randomized controlled trial to measure the&#xD;
      effect of this intervention on health outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty with recruitment and staff retention.&#xD;
  </why_stopped>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">November 13, 2019</completion_date>
  <primary_completion_date type="Actual">November 13, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Successful Discontinuation (Difference in Mean Number of Medications; Reduction in Dose)</measure>
    <time_frame>6 months</time_frame>
    <description>Difference in mean number of medications; number of medications reduced in dose</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mobility-related Fatigue</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Avlund Mob-T Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Physical Functioning</measure>
    <time_frame>Baseline, 6 Months</time_frame>
    <description>Manty survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Baseline, 6 Months</time_frame>
    <description>Brief Pain Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Falls</measure>
    <time_frame>Baseline, 6 Months</time_frame>
    <description>Total count of falls recorded in hospital admissions, primary care records and patient report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>Baseline, 6 Months</time_frame>
    <description>Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in Medication Side Effects and Symptoms</measure>
    <time_frame>1-week, 3-month, 6-month</time_frame>
    <description>Patient self-report change in symptoms, side effects, health improvements and problems</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious Adverse Events</measure>
    <time_frame>1-week, 3-month, 6-month</time_frame>
    <description>Any event that requires in-patient hospitalization or prolongation of existing hospitalization, causes congenital malformation, results in persistent or significant disability or incapacity, is life-threatening or results in death (Health Canada (2011) Guidance Document for Industry - Reporting Adverse Reactions to Marketed Health Products)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>EQ5D-5L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Functioning Performance</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Timed-up and go Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Functioning Performance</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Timed 8-foot walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance of Activities of Daily Living</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Barthel Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strength</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Hand grip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Ability</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Functional ability scale for the elderly</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare Utilization</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Cost of hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare Utilization</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Count of Emergency room visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare Utilization</measure>
    <time_frame>Baseline, 6-months</time_frame>
    <description>Number of clinic visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility Outcomes</measure>
    <time_frame>6 months</time_frame>
    <description>Number of participants that refuse recruitment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility Outcomes</measure>
    <time_frame>6 months</time_frame>
    <description>Retention rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility Outcomes</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>number of canceled appointments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility Outcomes</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Time to complete measures</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Multi-morbidity</condition>
  <condition>Medication Therapy Management</condition>
  <condition>Polypharmacy</condition>
  <arm_group>
    <arm_group_label>TAPERMD</arm_group_label>
    <description>80 Long term care residents on 5 or more medications aged over 70 from 2 long term care facilities</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TAPER</intervention_name>
    <description>The intervention is medication reduction. This arm is comprised of:&#xD;
Medication reconciliation&#xD;
Identification of patient priorities for care&#xD;
Identification of medications that are potentially appropriate for discontinuation/dose reduction&#xD;
Linked pharmacist/family physician consultations with patient to discuss medication with intention to reduce&#xD;
Identification of medications for trial of discontinuation/dose reduction (shared decision making)&#xD;
Pause of medication and clinical monitoring</description>
    <arm_group_label>TAPERMD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults, 70 years of age or older, residing in 2 long-term care facilities located in the&#xD;
        Brampton, Ontario, Canada.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  residing in 2 long-term care facilities in Brampton, ON&#xD;
&#xD;
          -  on 5 or more medications&#xD;
&#xD;
          -  70 years of age or older&#xD;
&#xD;
          -  adequate English language&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8P 1H6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 23, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2017</study_first_posted>
  <results_first_submitted>August 11, 2021</results_first_submitted>
  <results_first_submitted_qc>August 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 8, 2021</results_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Polypharmacy</keyword>
  <keyword>Mobility</keyword>
  <keyword>Multimorbidity</keyword>
  <keyword>Drug Discontinuation</keyword>
  <keyword>Patient Preference</keyword>
  <keyword>eHealth</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be available on request to the Principal investigator. The data set will be uploaded as required for publication.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT03202264/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>TAPERMD</title>
          <description>80 Long term care residents on 5 or more medications aged over 70 from 2 long term care facilities&#xD;
TAPER: The intervention is medication reduction. This arm is comprised of:&#xD;
Medication reconciliation&#xD;
Identification of patient priorities for care&#xD;
Identification of medications that are potentially appropriate for discontinuation/dose reduction&#xD;
Linked pharmacist/family physician consultations with patient to discuss medication with intention to reduce&#xD;
Identification of medications for trial of discontinuation/dose reduction (shared decision making)&#xD;
Pause of medication and clinical monitoring</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>TAPERMD</title>
          <description>80 Long term care residents on 5 or more medications aged over 70 from 2 long term care facilities&#xD;
TAPER: The intervention is medication reduction. This arm is comprised of:&#xD;
Medication reconciliation&#xD;
Identification of patient priorities for care&#xD;
Identification of medications that are potentially appropriate for discontinuation/dose reduction&#xD;
Linked pharmacist/family physician consultations with patient to discuss medication with intention to reduce&#xD;
Identification of medications for trial of discontinuation/dose reduction (shared decision making)&#xD;
Pause of medication and clinical monitoring</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Two participants died prior to data collection.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="90" spread="6.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Two participants died prior to data collection.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Successful Discontinuation (Difference in Mean Number of Medications; Reduction in Dose)</title>
        <description>Difference in mean number of medications; number of medications reduced in dose</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>TAPERMD</title>
            <description>80 Long term care residents on 5 or more medications aged over 70 from 2 long term care facilities&#xD;
TAPER: The intervention is medication reduction. This arm is comprised of:&#xD;
Medication reconciliation&#xD;
Identification of patient priorities for care&#xD;
Identification of medications that are potentially appropriate for discontinuation/dose reduction&#xD;
Linked pharmacist/family physician consultations with patient to discuss medication with intention to reduce&#xD;
Identification of medications for trial of discontinuation/dose reduction (shared decision making)&#xD;
Pause of medication and clinical monitoring</description>
          </group>
        </group_list>
        <measure>
          <title>Successful Discontinuation (Difference in Mean Number of Medications; Reduction in Dose)</title>
          <description>Difference in mean number of medications; number of medications reduced in dose</description>
          <units>Medications Changed</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.43" spread="2.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mobility-related Fatigue</title>
        <description>Avlund Mob-T Scale</description>
        <time_frame>Baseline, 6 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Level of Physical Functioning</title>
        <description>Manty survey</description>
        <time_frame>Baseline, 6 Months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain</title>
        <description>Brief Pain Inventory</description>
        <time_frame>Baseline, 6 Months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Falls</title>
        <description>Total count of falls recorded in hospital admissions, primary care records and patient report</description>
        <time_frame>Baseline, 6 Months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep</title>
        <description>Pittsburgh Sleep Quality Index</description>
        <time_frame>Baseline, 6 Months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Decrease in Medication Side Effects and Symptoms</title>
        <description>Patient self-report change in symptoms, side effects, health improvements and problems</description>
        <time_frame>1-week, 3-month, 6-month</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serious Adverse Events</title>
        <description>Any event that requires in-patient hospitalization or prolongation of existing hospitalization, causes congenital malformation, results in persistent or significant disability or incapacity, is life-threatening or results in death (Health Canada (2011) Guidance Document for Industry - Reporting Adverse Reactions to Marketed Health Products)</description>
        <time_frame>1-week, 3-month, 6-month</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life</title>
        <description>EQ5D-5L</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physical Functioning Performance</title>
        <description>Timed-up and go Test</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physical Functioning Performance</title>
        <description>Timed 8-foot walk test</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Performance of Activities of Daily Living</title>
        <description>Barthel Index</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Strength</title>
        <description>Hand grip</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Functional Ability</title>
        <description>Functional ability scale for the elderly</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Healthcare Utilization</title>
        <description>Cost of hospitalizations</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Healthcare Utilization</title>
        <description>Count of Emergency room visits</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Healthcare Utilization</title>
        <description>Number of clinic visits</description>
        <time_frame>Baseline, 6-months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Feasibility Outcomes</title>
        <description>Number of participants that refuse recruitment</description>
        <time_frame>6 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Feasibility Outcomes</title>
        <description>Retention rates</description>
        <time_frame>6 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Feasibility Outcomes</title>
        <description>number of canceled appointments</description>
        <time_frame>Baseline, 6 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Feasibility Outcomes</title>
        <description>Time to complete measures</description>
        <time_frame>Baseline, 6 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months from Physician Visit to Follow-up.</time_frame>
      <desc>Events were recorded via patient chart audit.</desc>
      <group_list>
        <group group_id="E1">
          <title>TAPERMD</title>
          <description>80 Long term care residents on 5 or more medications aged over 70 from 2 long term care facilities&#xD;
TAPER: The intervention is medication reduction. This arm is comprised of:&#xD;
Medication reconciliation&#xD;
Identification of patient priorities for care&#xD;
Identification of medications that are potentially appropriate for discontinuation/dose reduction&#xD;
Linked pharmacist/family physician consultations with patient to discuss medication with intention to reduce&#xD;
Identification of medications for trial of discontinuation/dose reduction (shared decision making)&#xD;
Pause of medication and clinical monitoring</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>wound infested with maggots</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>vertebral fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>decreased level of consciousness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>AECOPD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>increased leg edema</sub_title>
                <description>History of congestive heart failure</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall resulting in no or minor injury</sub_title>
                <counts group_id="E1" events="16" subjects_affected="9" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Tooth extraction &amp; complications</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>diagnosed with diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>worsening of Parkinson's Disease with dementia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>large skin tear/pressure ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Dee Mangin</name_or_title>
      <organization>McMaster University</organization>
      <phone>905-525-9140 ext 21219</phone>
      <email>mangind@mcmaster.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

